Pharma and Biotech CRM Software Market to Reach $9.85 Billion by 2034

Pharma and Biotech CRM Software Market to Reach $9.85 Billion by 2034

2025-11-17 companies

New York, Monday, 17 November 2025.
The global CRM market for pharmaceuticals and biotech is set to grow significantly, driven by AI and cloud solutions, with major players holding 95% market share.

Market Growth Projections

The global market for pharmaceutical and biotech CRM software is anticipated to reach $9.85 billion by 2034, propelled by advancements in AI-driven customer relationship management systems and cloud-based solutions [1]. This growth is particularly advantageous for small and medium enterprises (SMEs) within the sector, offering scalable and efficient platforms for customer engagement and data management. The market, valued at $4.33 billion in 2024, is set to grow at a compound annual growth rate (CAGR) of 8.49% as it expands over the next decade [1].

Dominance of Key Players

Currently, the market is heavily dominated by the top ten players, who collectively account for approximately 95% of the market share, with Veeva Systems Inc. (NYSE: VEEV) leading with a 26.81% share [1]. Such market concentration underscores the influence these companies have in directing industry trends and technological advancements. Veeva Systems’ leadership position is further reinforced by its strategic investments in AI and cloud technologies, as highlighted during the 2025 Veeva Commercial Summit [2].

Technological and Regional Opportunities

Significant growth opportunities exist in the AI CRM segment, expected to grow at a 14.60% CAGR from 2024 to 2029, alongside cloud-based deployments, which are projected to increase at a 9.91% CAGR [1]. Regional growth is anticipated in the Asia Pacific and Middle Eastern markets, with CAGRs of 10.02% and 9.53%, respectively [1]. These regions present lucrative opportunities for CRM providers looking to expand their footprints in emerging markets with increasing pharmaceutical sales.

Strategic Directions and Challenges

The market’s evolution is shaped by key trends such as the integration of electronic health records, strategic partnerships, and the development of voice-controlled CRM interfaces [1]. However, challenges such as resistance to digital adoption, talent shortages, and the impact of trade wars pose potential hurdles to seamless growth [1]. Companies must navigate these complexities while leveraging AI and cloud technologies to maintain competitive advantages in a rapidly transforming landscape.

Sources


CRM software biotech market